Carboxylesterase 1 c.428G>A single nucleotide variation increases the antiplatelet effects of clopidogrel by reducing its hydrolysis in humans
- 19 February 2015
- journal article
- research article
- Published by Wiley in Cancer Cell
- Vol. 97 (6), 650-658
- https://doi.org/10.1002/cpt.101
Abstract
Carboxylesterase 1 (CES1) hydrolyzes the prodrug clopidogrel to an inactive carboxylic acid metabolite. We studied the pharmacokinetics and pharmacodynamics of 600 mg oral clopidogrel in healthy white volunteers, including 10 carriers and 12 noncarriers of CES1 c.428G>A (p.Gly143Glu, rs71647871) single nucleotide variation (SNV). Clopidogrel carboxylic acid to clopidogrel area under the plasma concentration‐time curve from 0 hours to infinity (AUC0–∞) ratio was 53% less in CES1 c.428G>A carriers than in noncarriers (P = 0.009), indicating impaired hydrolysis of clopidogrel. Consequently, the AUC0–∞ of clopidogrel and its active metabolite were 123% (P = 0.004) and 67% (P = 0.009) larger in the c.428G>A carriers than in noncarriers. Consistent with these findings, the average inhibition of P2Y12‐mediated platelet aggregation 0–12 hours after clopidogrel intake was 19 percentage points higher in the c.428G>A carriers than in noncarriers (P = 0.036). In conclusion, the CES1 c.428G>A SNV increases clopidogrel active metabolite concentrations and antiplatelet effects by reducing clopidogrel hydrolysis to inactive metabolites.Keywords
This publication has 43 references indexed in Scilit:
- The Role of Human Carboxylesterases in Drug Metabolism: Have We Overlooked Their Importance?Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2013
- Cytochromes P450 Catalyze Both Steps of the Major Pathway of Clopidogrel Bioactivation, whereas Paraoxonase Catalyzes the Formation of a Minor Thiol Metabolite IsomerChemical Research in Toxicology, 2011
- Development and validation of an HPLC–MS/MS method to quantify clopidogrel acyl glucuronide, clopidogrel acid metabolite, and clopidogrel in plasma samples avoiding analyte back-conversionAnalytical and Bioanalytical Chemistry, 2011
- Carboxylesterase 1 (Ces1): from monocyte marker to major playerJournal of Clinical Pathology, 2010
- Metabolism and Disposition of the Thienopyridine Antiplatelet Drugs Ticlopidine, Clopidogrel, and Prasugrel in HumansThe Journal of Clinical Pharmacology, 2010
- A Possible Mechanism for the Differences in Efficiency and Variability of Active Metabolite Formation from Thienopyridine Antiplatelet Agents, Prasugrel and ClopidogrelPublished by American Society for Pharmacology & Experimental Therapeutics (ASPET) ,2009
- Antiplatelet Agents Aspirin and Clopidogrel Are Hydrolyzed by Distinct Carboxylesterases, and Clopidogrel Is Transesterificated in the Presence of Ethyl AlcoholJournal of Pharmacology and Experimental Therapeutics, 2006
- Structure, function and regulation of carboxylesterasesChemico-Biological Interactions, 2006
- THE MAMMALIAN CARBOXYLESTERASES: From Molecules to FunctionsAnnual Review of Pharmacology and Toxicology, 1998
- Clopidogrel inhibits the binding of ADP analogues to the receptor mediating inhibition of platelet adenylate cyclase.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1992